Nonproliferative and proliferative lesions of the rat and mouse female reproductive system

Journal of Toxicologic Pathology

Volumn 27, Issue 3-4, 2014, Pages

  Dixon, Darlene ^a   Alison, Roger ^b   Bach, Ute ^c   Colman, Karyn ^d   Foley, George L ^e   Harleman, Johannes H ^f   Haworth, Richard ^g   Herbert, Ronald ^a   Heuser, Anke ^h   Long, Gerald ⁱ   Mirsky, Michael ^j   Regan, Karen ^k   van Esch, Eric ^l   Westwood, F Russell ^m   Vidal, Justin ⁿ   Yoshida, Midori ^o  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Pathology Consultancy Services   (United Kingdom)

^c BAYER PHARMA AG   (Germany)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e ABBVIE INC   (United States)

^f Fresenius Kabi Deutschland GmbH   (Germany)

^g GLAXOSMITHKLINE   (United Kingdom)

^h F HOFFMANN LA ROCHE LTD   (Switzerland)

ⁱ Experimental Pathology Laboratories   (United States)

^j PFIZER INC   (United States)

^k Regan Path/Tox Services   (United States)

^l InSight Pathology BV   (Netherlands)

^m ASTRAZENECA   (United Kingdom)

ⁿ GLAXOSMITHKLINE   (United States)

^o NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

more..

Author keywords

Cervix; Diagnostic pathology; Female reproductive; Nomenclature; Ovary; Uterus; Vagina

Indexed keywords

ADENOMYOSIS; AGING; ARTICLE; AUTOPSY; CELL VACUOLE; CLINICAL FEATURE; CORPUS LUTEUM; DECIDUALIZATION; DIESTRUS; DIFFERENTIAL DIAGNOSIS; DYSGERMINOMA; ECTOPIC OVARY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM POLYP; ESTRUS; FOLLICLE CYST; GRANULOSA CELL; GYNECOLOGIC DISEASE; HUMAN; LUTEOMA; METESTRUS; METRITIS; MINERALIZATION; MOUSE MODEL; NEURILEMOMA; NONHUMAN; OVARY AMYLOIDOSIS; OVARY ATROPHY; OVARY CYSTADENOCARCINOMA; OVARY CYSTADENOMA; OVARY DISEASE; OVARY EDEMA; OVARY HYPERPLASIA; OVARY HYPERTROPHY; OVARY INFLAMMATION; OVARY TERATOMA; PATHOGENESIS; PELVIC ORGAN PROLAPSE; PROESTRUS; PYOMETRA; RAT MODEL; THECA CELL; THECOMA; UTERINE CERVICITIS; UTERINE CERVIX ADENOSIS; UTERINE CERVIX ATROPHY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DISEASE; UTERINE CERVIX HYPERTROPHY; UTERINE CERVIX KERATOACANTHOMA; UTERINE CERVIX LEIOMYOMA; UTERINE CERVIX LEIOMYOSARCOMA; UTERINE CERVIX NECROSIS; UTERINE CERVIX PAPILLOMA; UTERINE CERVIX PROLAPSE; UTERINE CERVIX STROMA; UTERUS APLASIA; UTERUS ATROPHY; UTERUS CARCINOMA; UTERUS DISEASE; UTERUS FIBROSIS; UTERUS GRANULOMA; UTERUS HYPERPLASIA; UTERUS HYPERTROPHY; UTERUS HYPOPLASIA; UTERUS METAPLASIA; UTERUS MYOMA; UTERUS NECROSIS; UTERUS PROLAPSE; UTERUS SARCOMA; UTERUS TERATOMA; VAGINA ADENOSIS; VAGINA ATRESIA; VAGINA ATROPHY; VAGINA DISEASE; VAGINA KERATOACANTHOMA; VAGINA LEIOMYOMA; VAGINA LEIOMYOSARCOMA; VAGINA NECROSIS; VAGINA PAPILLOMA; VAGINITIS;

EID: 84929470263     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.27.1S     Document Type: Article

References (214)

1. Alison RH, Lewis DJ, and Montgomery CA. Ovarian choriocarcinoma in the mouse. Vet Pathol. 24: 226–230.1987a.
2. Alison RH, and Morgan KT. Ovarian neoplasms in F344 rats and B6C3F1 mice. Environ Health Perspect. 73: 91–106.1987a.
3. Alison RH, and Morgan KT. Granulosa cell tumor, ovary, mouse. In: Monographs on pathology of laboratory animals. Genital System. Jones TC, Mohr U, and Hunt RD (eds). Springer-Verlag, Berlin, Heidelberg, New York. 22–30. 1987b.
4. Alison RH, Morgan KT, Haseman JK, and Boorman GA. Morphology and classification of ovarian neoplasms in F344 rats and (C57BL/6 X C3H)F1 mice. J Natl Cancer Inst. 78: 1229–1243. 1987b.
5. Alison RH, Morgan KT, and Montgomery CA. Ovary. In: Pathology of the Fischer rat. Reference and atlas. Boorman GA, Eustis SL, Elwell MR, Montgomery CA, Jr, and MacKenzie WF (eds). Academic Press, San Diego, New York, London. 429–442. 1990.
6. Amadi K, Nwana EJ, and Otubu JA. Morphology and function of the rat oviduct: effects of thyroidectomy and thyroxine administration. Afr J Med Med Sci. 36: 353–358. 2007.
7. Andrews P, Freyberger A, Hartmann E, Eiben R, Loof I, Schmidt U, Temerowski M, Folkerts A, Stahl B, and Kayser M. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407). Arch Toxicol. 76: 194–202. 2002.
8. Anisimov VN, and Nikonov AA. Tumours of the vagina, uterus and oviduct. In: Pathology of tumours in laboratory animals. Vol 1. Tumours of the rat, 2nd edition. Turusov VS, and Mohr U (eds). IARC Scientific Publications No. 99, Lyon. 445–471. 1990.
9. Ashley DJB. Evan’s histological appearances of tumors. Churchill Livingstone, Edinburgh. 1990.
10. Berger L, El-Alfy M, Martel C, and Labrie F. Effects of dehydroepiandrosterone, Premarin and Acolbifene on histomorphology and sex steroid receptors in the rat vagina. J Steroid Biochem Mol Biol. 96: 201–215. 2005.
11. Biegel LB, Flaws JA, Hirshfield AN, O’Connor JC, Elliott GS, Ladics GS, Silbergeld EK, Van Pelt CS, Hurtt ME, Cook JC, and Frame SR. 90-day feeding and one-generation reproduction study in Crl:CD BR rats with 17 beta-estradiol. Toxicol Sci. 44: 116–142. 1998.
12. Bolon B, Bucci TJ, Warbritton AR, Chen JJ, Mattison DR, and Heindel JJ. Differential follicle counts as a screen for chemically induced ovarian toxicity in mice: results from continuous breeding bioassays. Fundam Appl Toxicol. 39: 1–10. 1997.
13. Branham WS, Zehr DR, Chen JJ, and Sheehan DM. Alterations in developing rat uterine cell populations after neonatal exposure to estrogens and antiestrogens. Teratology. 38: 271–279. 1988.
14. Brossia LJ, Roberts CS, Lopez JT, Bigsby RM, and Dynlacht JR. Interstrain differences in the development of pyometra after estrogen treatment of rats. J Am Assoc Lab Anim Sci. 48: 517–520. 2009.
15. Brown H, and Leininger JR. Alterations of the uterus. In: Pathobiology of the aging rat. Mohr U, Dungworth DL, and Capen CC (eds). ILSI Press, Washington DC. 377–388. 1992.
16. Busch K, and Naglić T. Natural uterine Mycoplasma pulmonis infection in female rats. Vet Med (Praha). 40: 253–255. 1995.
17. Campbell JS. Adenoacanthoma, uterus, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 110–115. 1987.
18. Cardesa A, Ribalta T, Vogeley KT, Reifenberger G, Wechsler W, and Turusov VS. Tumours of the peripheral nervous system. In: Pathology of tumours in laboratory animals. Vol 1. Tumours of the rat, 2nd edition. Turusov VS, Mohr U (eds). IARC Scientific Publications No. 99, Lyon. 699–724. 1990.
19. Carthew P, Edwards RE, Nolan BM, Martin EA, and Smith LL. Tamoxifen associated uterine pathology in rodents: relevance to women. Carcinogenesis. 17: 1577–1582. 1996.
20. Chamness GC, Bannayan GA, Landry LA Jr, Sheridan PJ, and McGuire WL. Abnormal reproductive development in rats after neonatally administered antiestrogen (tamoxifen). Biol Reprod. 21: 1087–1090. 1979.
21. Chen Y, Jefferson WN, Newbold RR, Padilla-Banks E, and Pepling ME. Estradiol, progesterone, and genistein inhibit oocyte nest breakdown and primordial follicle assembly in the neonatal mouse ovary in vitro and in vivo. Endocrinology. 148: 3580–3590. 2007.
22. Ciaccio LA, Hill JL, and Kincl FA. Observation on toxic effects of quinacrine hydrochloride (in rodents). Contraception. 17: 231–236. 1978.
23. Clement PB. Non-neoplastic lesions of the ovary. In: Blaustein’s Pathology of the Female Genital Tract. Kurman RJ (ed). Springer-Verlag, New York. 676–677. 2002.
24. Clow OL, Hurst PR, and Fleming JS. Changes in the mouse ovarian surface epithelium with age and ovulation number. Mol Cell Endocrinol. 191: 105–111. 2002.
25. Comereski CR, Peden WM, Davidson TJ, Warner GL, Hirth RS, and Frantz JD. BR96-doxorubicin conjugate (BMS-182248) versus doxorubicin: a comparative toxicity assessment in rats. Toxicol Pathol. 22: 473–488. 1994.
26. Corbeil LB, Chatterjee A, Foresman L, and Westfall JA. Ultrastructure of cyclic changes in the murine uterus, cervix, and vagina. Tissue Cell. 17: 53–68. 1985.
27. Cornillie FJ, and Lauweryns JM. Phagocytotic and iron-storing capacities of stromal cells in the rat endometrium. A histochemical and ultrastructural study. Cell Tissue Res. 239: 467–476. 1985.
28. Coskun A, Coban YK, and Ciralik H. Critical ischemic time for the rat ovary: experimental study evaluating early histopathologic changes. J Obstet Gynaecol Res. 35: 330–334. 2009.
29. Courtney CL, Hawkins KL, Meierhenry EF, and Graziano MJ. Immunohistochemical and ultrastructural characterization of granular cell tumors of the female reproductive tract in two aged Wistar rats. Vet Pathol. 29: 86–89. 1992.
30. Davis BJ, Almekinder JL, Flagler N, Travlos G, Wilson R, and Maronpot RR. Ovarian luteal cell toxicity of ethylene glycol monomethyl ether and methoxy acetic acid in vivo and in vitro. Toxicol Appl Pharmacol. 142: 328–337. 1997.
31. Davis BJ, Dixon D, and Herbert RA. Ovary, oviduct, uterus, cervix, and vagina. In: Pathology of the mouse. Reference and atlas. Maronpot RR, Boorman GA, and Gaul BW (eds). Cache River Press, Vienna. 409–443. 1999.
32. Davis BJ, Harleman JH, Heinrichs M, Maekawa A, McConnell RF, Reznik G, and Tucker M. Female genital system. In: International Classification of Rodent Tumors: The Mouse. Mohr U (ed). Springer-Verlag, Heidelberg, Berlin, New York. 211–268. 2001.
33. Davis JK, Gaertner DJ, Cox NR, Lindsey JR, Cassell GH, Davidson MK, Kervin KC, and Rao GN. The role of Klebsiella oxytoca in utero-ovarian infection of B6C3F1 mice. Lab Anim Sci. 37: 159–166. 1987.
34. de la Maza LM, Pal S, Khamesipour A, and Peterson EM. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun. 62: 2094–2097. 1994.
35. Deerberg F, Pohlmeyer G, Lörcher K, and Petrow V. Total suppression of spontaneous endometrial carcinoma in BDII/Han rats by melengestrol acetate. Oncology. 52: 319–325. 1995.
36. Deerberg F, Rehm S, and Pittermann W. Uncommon frequency of adenocarcinomas of the uterus in virgin Han:Wistar rats. Vet Pathol. 18: 707–713. 1981.
37. Diters RW, Funk KA, Fang H, Durham SK, and Mense MG. Hermaphroditism in a Sprague-Dawley rat. Vet Pathol. 44: 418–420. 2007.
38. Dixon D, Couse JF, and Korach KS. Disruption of the estrogen receptor gene in mice. Toxicol Pathol. 25: 518–520. 1997.
39. Dixon D, Leininger JR, Valerio MG, Johnson AN, Stabinski LG, and Frith CH. Proliferative lesions of the ovary, uterus, vagina, cervix and oviduct in rats. In Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC. 1999.
40. Dodo T, Taketa Y, Sugiyama M, Inomata A, Sonoda J, Okuda Y, Mineshima H, Hosokawa S, and Aoki T. Collaborative work on evaluation of ovarian toxicity. (11) Two- or four-week repeated-dose studies and fertility study of ethylene glycol monomethyl ether in female rats. J Toxicol Sci. 34(Suppl 1): SP121–SP128. 2009.
41. Durlinger AL, Kramer P, Karels B, Grootegoed JA, Uilenbroek JT, and Themmen AP. Apoptotic and proliferative changes during induced atresia of pre-ovulatory follicles in the rat. Hum Reprod. 15: 2504–2511. 2000.
42. Elwell M, Mahler JF, and Ruecker FA. Proliferative and non-proliferative lesions in the heart and vasculature in mice. In Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC. 2004.
43. Engle ET. Tubular adenomas and testis-like tubules of the ovaries of aged rats. Cancer Res. 6: 578–582. 1946.
44. Ennis BW, and Davies J. Reproductive tract abnormalities in rats treated neonatally with DES. Am J Anat. 164: 145–154. 1982.
45. Ernst H, Carlton WW, Courtney C, Rinke M, Greaves P, Isaacs KR, Krinke G, Konishi Y, Mesfin GM, and Sandusky G. Soft tissue and skeletal muscle. In: International Classification of Rodent Tumors. The Mouse. Mohr U (ed). Springer, Heidelberg, Berlin, New York. WHO IARK 361–387. 2001a.
46. Ernst H, Carlton WW, Courtney C, Rinke M, Greaves P, Isaacs KR, Krinke G, Konishi Y, Mesfin GM, and Sandusky G. Soft tissue and skeletal muscle. In: International Classification of Rodent Tumors. The Mouse. Mohr U (ed). Springer, Heidelberg, Berlin, New York. WHO IARK. 2001b.
47. Faccini JM, Abbott DP, and Paulus GJJ. Mouse histopathology. A glossary for use in toxicity and carcinogenicity studies. Elsevier, Amsterdam, New York, Oxford. 1990.
48. Fleming JS, McQuillan HJ, Millier MJ, Beaugié CR, and Livingstone V. Ecadherin expression and bromodeoxyuridine incorporation during development of ovarian inclusion cysts in age-matched breeder and incessantly ovulated CD-1 mice. Reprod Biol Endocrinol. 5: 14. 2007.
49. Forsberg JG, and Kalland T. Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res. 41: 721–734. 1981.
50. Frith CH, and Chandra M. Incidence, distribution, and morphology of amyloidosis in Charles Rivers CD-1 mice. Toxicol Pathol. 19: 123–127. 1991.
51. Frith CH, and Ward JM. Color atlas of neoplastic and non-neoplastic lesions in aging mice. Elsevier, Amsterdam, New York, Tokyo. 1988.
52. Frith CH, Ward JM, Harleman JH, Stromberg PC, Halm S, Inoue T, and Wright JA. Hematopoietic System. In: International classification of rodent tumors in the mouse. Mohr U (ed). Springer, Berlin. 417–451. 2001.
53. Gaytán M, Bellido C, Morales C, Sánchez-Criado JE, and Gaytán F. Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat. Reproduction. 132: 571–577. 2006.
54. Geist SH, and Lüllmann-Rauch R. Experimentally induced lipidosis in uterine and vaginal epithelium of rats. Ann Anat. 176: 3–9. 1994.
55. Genadry R, Parmley T, and Woodruff JD. The origin and clinical behavior of the parovarian tumor. Am J Obstet Gynecol. 129: 873–880. 1977.
56. Ginty I, and Hoogstraten-Miller S. Perineal swelling in a mouse. Diagnosis: imperforate vagina with secondary mucometra. Lab Anim (NY). 37: 196–199. 2008.
57. Goldman JM, Murr AS, and Cooper RL. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol. 80: 84–97. 2007.
58. Goodman DG, and Hildebrandt PK. Adenocarcinoma, endometrium, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 80–82. 1987a.
59. Goodman DG, and Hildebrandt PK. Stromal polyp, endometrium, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 146–148. 1987b.
60. Goodman DG, and Hildebrandt PK. Papillary adenoma, endometrium, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 78–80. 1987c.
61. Goodman DG, and Hildebrandt PK. Squamous cell carcinoma, endometrium/ cervix, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 82–83. 1987d.
62. Goodman DG, and Hildebrandt PK. Stromal sarcoma, endometrium, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 70–72. 1987e.
63. Gopinath C, and Gibson WA. Mesovarian leiomyomas in the rat. Environ Health Perspect. 73: 107–113. 1987.
64. Gopinath C, Prentice DE, and Lewis DJ. The respiratory system. In: Atlas of experimental pathology. MTP Press, Lancaster, Boston, The Hague, Dordrecht. 1987.
65. Graham CE. Cyclic changes in the squamo-columnar junction of the mouse cervix uteri. Anat Rec. 155: 251–260. 1966.
66. Greaves P. Female genital tract. In: Histopathology of Preclinical Toxicity Studies. 4th ed. Elsevier, Amsterdam. 667–723. 2012.
67. Greaves P, Carlton WW, Courtney CL, Ernst H, Halm S, Isaacs KR, Konishi Y, Krinke GJ, Mesfin GM, Rinke M, and Sandusky G. Non-proliferative and proliferative lesions of soft tissues and skeletal muscle in mice. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington DC. 1–18. 2004.
68. Greaves P, and Faccini JM. Rat histopathology. A glossary for use in toxicity and carcinogenicity studies. Elsevier, Amsterdam, New York, Oxford. 1984.
69. Greaves P, Faccini JM, and Courtney CL. Proliferative lesions of soft tissues and skeletal muscle in rats. In: Guides for Toxicologic Pathology. STP/ ARP/AFIP, Washington DC. 1–14. 1992.
70. Greaves P, and Seely JC. Non-proliferative lesions of soft tissues and skeletal muscle in rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP. MST-1. Washington DC. 292–299. 1996.
71. Gregson RL, Lewis DJ, and Abbott DP. Spontaneous ovarian neoplasms of the laboratory rat. Vet Pathol. 21: 292–299. 1984.
72. Hao X, Fredrickson TN, Chattopadhyay SK, Han W, Qi CF, Wang Z, Ward JM, Hartley JW, and Morse HC. The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. Vet Pathol. 47: 434–445. 2010.
73. Harada M, Kishimoto K, Hagiwara R, Nakashima Y, Kurisu K, and Kawaguchi Y. Infertility observed in female rats treated with N-acetyl-L-cysteine: Histopathological examination of ovarian follicles and recovery of fertility. Congenit Anom (Kyoto). 43: 168–176. 2003.
74. Hart-Elcock L, Stuart BP, Mueller RE, and Hoss HE. Deciduoma, uterus, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 140–146. 1987.
75. Hendry WJ, Zheng X, Leavitt WW, Branham WS, and Sheehan DM. Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri. Cancer Res. 57: 1903–1908. 1997.
76. Heywood R, and Wadsworth PF. The experimental toxicology of estrogens. In: Pharmacology of Estrogens (International Encyclopedia of Pharmacology and Therapeutics). Chaudhury RR (ed). Pergamon Press, New York. Vol. Section 106, 68. 1981.
77. Hirshfield AN, and Midgley AR. Morphometric analysis of follicular development in the rat. Biol Reprod. 19: 597–605. 1978.
78. Hollander CF, Burek JD, Boorman GA, Snell KC, and Laqueur GL. Granular cell tumors of the central nervous system of rats. Arch Pathol Lab Med. 100: 445–447. 1976.
79. Hoyer PB. Can the clock be turned back on ovarian aging? Sci SAGE KE. 2004: pe11. 2004.
80. Iguchi T, Hirokawa M, and Takasugi N. Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology. 42: 1–11. 1986.
81. Ioannidis N. Lipidosis induced in rat uteri by high doses of tamoxifen. Ann Anat. 180: 315–319. 1998.
82. Ishii S, Ube M, Okada M, Adachi T, Sugimoto J, Inoue Y, Uno Y, and Mutai M. Collaborative work on evaluation of ovarian toxicity. (17) Two- or fourweek repeated-dose studies and fertility study of sulpiride in female rats. J Toxicol Sci. 34(Suppl 1): SP175–SP188. 2009.
83. Ito A, Mafune N, and Kimura T. Collaborative work on evaluation of ovarian toxicity. (4) Two- or four-week repeated dose study of 4-vinylcyclohexene diepoxide in female rats. J Toxicol Sci. 34(Suppl 1): SP53–SP58. 2009.
84. Izumi Y, Watanabe T, Awasaki N, Hikawa K, Minagi T, and Chatani F. Collaborative work on evaluation of ovarian toxicity. (16) Effects of 2 or 4 weeks repeated dose studies and fertility study of Chlorpromazine hydrochloride in rats. J Toxicol Sci. 34(Suppl 1): SP167–SP174. 2009.
85. Jarrett RJ. Some endocrine effects of two phenothiazine derivatives, chlorpromazine and perphenazine, in the female mouse. Br Pharmacol Chemother. 20: 497–506. 1963.
86. Johnson LD. Lesions of the female genital system caused by diethylstilbestrol in humans, subhuman primates, mice. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 84–109. 1987.
87. Jones TC, Hunt RD, and King NW. Veterinary pathology. Williams and Wilkins, Baltimore. 1997.
88. Kai K, Satoh N, Watanabe A, Shiraiwa K, Sasano H, and Furuhama K. Case report of rat true hermaphroditism: colocalization of oocytes and granulosa and sertoli cells in the germinal cord. Toxicol Pathol. 31: 290–294. 2003.
89. Kaipia A, and Hsueh AJ. Regulation of ovarian follicle atresia. Annu Rev Physiol. 59: 349–363. 1997.
90. Kao SW, Sipes IG, and Hoyer PB. Early effects of ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats and mice. Reprod Toxicol. 13: 67–75. 1999.
91. Kaspareit-Rittinghausen J, and Deerberg F. Spontaneous malignant mixed müllerian tumors and rhabdomyosarcoma of the uterus in rats. Toxicol Pathol. 18: 417–422. 1990.
92. Kaufmann W, Bolon B, Bradley A, Butt M, Czasch S, Garman RH, George C, Gröters S, Krinke G, Little P, McKay J, Narama I, Rao D, Shibutani M, and Sills R. Proliferative and nonproliferative lesions of the rat and mouse central and peripheral nervous systems. Toxicol Pathol. 40(Suppl): 87S–157S. 2012.
93. Kaushic C, Frauendorf E, Rossoll RM, Richardson JM, and Wira CR. Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract. Am J Reprod Immunol. 39: 209–216. 1998.
94. Kelly WA, Marler RJ, and Weikel JH. Drug-induced mesovarial leiomyomas in the rat - a review and additional data. J Am Coll Toxicol. 12: 13–22. 1993.
95. Kent HA. Polyovular follicles and multinucleate ova in the ovaries of young mice. Anat Rec. 137: 521–524. 1960.
96. Kent HA. Polyovular follicles and multinucleate ova in the ovaries of young rats. Anat Rec. 142: 25–29. 1962.
97. Ketani MA, Ketani S, Kaloğlu C, and Güney B. Effects of tamoxifen administration in rat vaginas: an ultrastructural and light microscopy study. Eur J Gynaecol Oncol. 23: 557–560. 2002.
98. Kim H, Nakajima T, Hayashi S, Chambon P, Watanabe H, Iguchi T, and Sato T. Effects of diethylstilbestrol on programmed oocyte death and induction of polyovular follicles in neonatal mouse ovaries. Biol Reprod. 81: 1002–1009. 2009.
99. King A, Gardner L, and Loke YW. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum Reprod. 11: 1079–1082. 1996.
100. Kodama T, Yoshida J, Miwa T, Hasegawa D, and Masuyama T. Collaborative work on evaluation of ovarian toxicity. (4) Effects of fertility study of 4-vinylcyclohexene diepoxide in female rats. J Toxicol Sci. 34(Suppl 1): SP59–SP63. 2009.
101. Kon Y, Konno A, Hashimoto Y, and Endoh D. Ovarian cysts in MRL/MpJ mice originate from rete ovarii. Anat Histol Embryol. 36: 172–178. 2007.
102. Krinke G, Naylor DC, Schmid S, Fröhlich E, and Schnider K. The incidence of naturally-occurring primary brain tumours in the laboratory rat. J Comp Path. 95: 175–192.1985.
103. Krinke GJ, Kaufmann W, Mahrous AT, and Schaetti P. Morphologic characterization of spontaneous nervous system tumors in mice and rats. Toxicol Pathol. 28: 178–192. 2000.
104. Kumazawa T, Nakajima A, Ishiguro T, Jiuxin Z, Tanaharu T, Nishitani H, Inoue Y, Harada S, Hayasaka I, and Tagawa Y. Collaborative work on evaluation of ovarian toxicity. (15) Two- or four-week repeated-dose studies and fertility study of bromocriptine in female rats. J Toxicol Sci. 34(Suppl 1): SP157–SP165. 2009.
105. Löseke A, and Spanel-Borowski K. Simple or repeated induction of superovulation: a study on ovulation rates and microvessel corrosion casts in ovaries of golden hamsters. Ann Anat. 178: 5–14. 1996.
106. Lúllmann-Rauch R, and Reil GH. Fenfluramine-induced ultrastructural alterations in tissues of rats and guinea pigs. Naunyn Schmiedebergs Arch Pharmacol. 285: 175–184. 1974.
107. Landes C, Heider K, Krinke AL, Krinke GJ, Mahrous AT, and Hess R. Contribution of immunohistochemistry toward the diagnosis of tumors of laboratory rats. Exp Pathol. 40: 239–250. 1990.
108. Lee S-H, Ichii O, Otsuka S, Elewa YH, Namiki Y, Hashimoto Y, and Kon Y. Ovarian cysts in MRL / MpJ mice are derived from the extraovarian rete: a developmental study. J Anat. 219: 743–755. 2011.
109. Leininger JR, and Jokinen MP. Oviduct, uterus and vagina. In: Pathology of the Fischer rat. Reference and atlas. Boorman GA, Eustis SL, Elwell MR, Montgomery CA, Jr, and MacKenzie WF (eds). Academic Press, San Diego, New York, London. 443–459. 1990.
110. Lemon PG, and Gubareva AV. Tumours of the ovary. In: Pathology of tumours in laboratory animals. Vol. 2. Tumours of the mouse. Turusov VS (ed). IARC Scientific Publications No. 23, Lyon. 385–409. 1979.
111. Lerner LJ, Hilf R, Turkheimer AR, Michel I, and Engel SL. Effects of hormone antagonists on morphological and biochemical changes induced by hormonal steroids in the immature rat uterus. Endocrinology. 78: 111–124. 1966.
112. Lewis DJ. Ovarian neoplasia in the Sprague-Dawley rat. Environ Health Perspect. 73: 77–90. 1987.
113. Li S, and Davis B. Evaluating rodent vaginal and uterine histology in toxicity studies. Birth Defects Res B Dev Reprod Toxicol. 80: 246–252. 2007.
114. Long GG. Apparent mesonephric duct (rete anlage) origin for cysts and proliferative epithelial lesions in the mouse ovary. Toxicol Pathol. 30: 592–598. 2002.
115. Long GG, Cohen IR, Gries CL, Young JK, Francis PC, and Capen CC. Proliferative lesions of ovarian granulosa cells and reversible hormonal changes induced in rats by a selective estrogen receptor modulator. Toxicol Pathol. 29: 719–726. 2001.
116. Maekawa A. Tumours of the ovary. In: Pathology of tumours in laboratory animals. Vol 1. Tumours of the rat, 2nd edition. Turusov VS, and Mohr U (eds). IARC Scientific Publications No. 99, Lyon. 473–497. 1990.
117. Maekawa A. Genital tumors in female rats—influence of chemicals and/or hormones and host factors on their occurrence. J Toxicol Sci. 19: 119–132. 1994.
118. Maekawa A, and Hayashi Y. Granulosa/theca cell tumor, ovary, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 15–22. 1987.
119. Maekawa A, and Maita K. Changes in the uterus and vagina. In: Pathobiology of the Aging Mouse. Mohr U, Dungworth DL, Capen CC, Carlton WW, JP Sundberg JP, and Ward JM (eds). ILSI Press, Washington, DC. 469–480. 1996.
120. Maekawa A, Maita K, and Harleman JH. Changes in the ovary. In: Pathobiology of the Aging Mouse. Vol 1. Mohr U, Dungworth DL, Capen CC, Carlton WW, JP Sundberg JP, and Ward JM (eds). ILSI Press, Washington, DC. 466. 1996.
121. Maekawa A, and Mitsumori K. Spontaneous occurrence and chemical induction of neurogenic tumors in rats—influence of host factors and specificity of chemical structure. Crit Rev Toxicol. 20: 287–310. 1990.
122. Majeed SK, Alison RH, Boorman GA, and Gopinath C. Ovarian yolk sac carcinoma in mice. Vet Pathol. 23: 776–778. 1986.
123. Markovits JE, and Sahota PS. Aromatase inhibitors prevent spontaneous granular cell tumors in the distal female reproductive tract of Sprague- Dawley rats. Toxicol Pathol. 28: 799–801. 2000a.
124. Markovits JE, and Sahota PS. Granular cell lesions in the distal female reproductive tract of aged Sprague-Dawley rats. Vet Pathol. 37: 439–448. 2000b.
125. Mattheij JA, and Swarts HJ. Induction of luteinized unruptured follicles in the rat after injection of luteinizing hormone early in pro-oestrus. Eur J Endocrinol. 132: 91–96. 1995.
126. McIntyre A, and La Perle KM. Hermaphroditism in 3 chimeric mice. Vet Pathol. 44: 249–252. 2007.
127. McLachlan JA, Newbold RR, and Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstil bestrol. Cancer Res. 40: 3988–3999. 1980.
128. Medlock KL, Branham WS, and Sheehan DM. Effects of toremifene on neonatal rat uterine growth and differentiation. Biol Reprod. 56: 1239–1244. 1997.
129. Mirsky ML, Sivaraman L, Houle C, Potter DM, Chapin RE, and Cappon GD. Histologic and cytologic detection of endocrine and reproductive tract effects of exemestane in female rats treated for up to twenty-eight days. Toxicol Pathol. 39: 589–605. 2011.
130. Mitsuhashi N, Takahashi T, Nozaki M, Matsumoto H, Sakurai H, Takahashi M, and Niibe H. Establishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis. Jpn J Cancer Res. 84: 1287–1291. 1993.
131. Miwa M, Kojima M, Ohtani T, and Tsuji K. [A recessive mutant causing testicular/ ovarian teratoma in rats (Tera strain)]. Jikken Dobutsu. 36: 205–208. 1987 (In Japanese).
132. Mobini Far HR, Agren G, Lindqvist AS, Marmendal M, Fahlke C, and Thiblin I. Administration of the anabolic androgenic steroid nandrolone decanoate to female rats causes alterations in the morphology of their uterus and a reduction in reproductive capacity. Eur J Obstet Gynecol Reprod Biol. 131: 189–197. 2007.
133. Montgomery CA, and Alison RH. Nonneoplastic lesions of the ovary in Fischer 344 rats and B6C3F1 mice. Environ Health Perspect. 73: 53–75. 1987.
134. Moore AB, He H, Yoshida A, Rico PJ, Haseman JK, and Dixon D. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice. Exp Toxicol Pathol. 52: 195–200. 2000.
135. Morgan KT, and Alison RH. Tubular adenoma, ovary, mouse. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg New York, Tokyo. 36–41. 1987.
136. Myers RK, and McGavin MD. Cellular and tissue responses to injury. In: Pathologic Basis of Veterinary Disease. Fourth Ed. McGavin MD, and Zachary JF (eds). Mosby Elsevier, St. Louis. 2007.
137. Nagaoka T, Takeuchi M, Onodera H, Matsushima Y, Ando-Lu J, and Maekawa A. Sequential observation of spontaneous endometrial adenocarcinoma development in Donryu rats. Toxicol Pathol. 22: 261–269. 1994.
138. National Toxicology Program Carcinogenesis Bioassay of Zearalenone (CAS No. 17924-92-4) in F344/N Rats and B6C3F1 Mice (Feed Study). Natl Toxicol Program Tech Rep Ser. 235: 1–155. 1982.
139. National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser. 443: 1–321.1993.
140. Nelson LW, Kelly WA, and Weikel JH. Mesovarial leiomyomas in rats in a chronic toxicity study of mesuprine hydrochloride. Toxicol Appl Pharmacol. 23: 731–737. 1972.
141. Newbold RR, Banks EP, Bullock B, and Jefferson WN. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res. 61: 4325–4328. 2001.
142. Newbold RR, Bullock BC, and McLachlan JA. Diverticulosis and salpingitis isthmica nodosa (SIN) of the fallopian tube. Estrogen-induced diverticulosis and SIN of the mouse oviduct. Am J Pathol. 117: 333–335. 1984.
143. Newbold RR, Jefferson WN, and Padilla-Banks E. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol. 24: 253–258. 2007.
144. Newbold RR, Jefferson WN, and Padilla-Banks E. Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect. 117: 879–885. 2009.
145. Newbold RR, and McLachlan JA. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res. 42: 2003–2011. 1982.
146. Newbold RR, Moore AB, and Dixon D. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol. 30: 611–616. 2002.
147. Nielsen SW, Misdorp W, and McEntee K. Tumours of the ovary. Bull World Health Organ. 53: 203–215. 1976.
148. Nomura T, and Kanzaki T. Induction of urogenital anomalies and some tumors in the progeny of mice receiving diethylstilbestrol during pregnancy. Cancer Res. 37: 1099–1104. 1977.
149. Nozaki Y, Furubo E, Matsuno T, Fukui R, Kizawa K, Kozaki T, and Sanzen T. Collaborative work on evaluation of ovarian toxicity. (6) Two- or fourweek repeated-dose studies and fertility study of cisplatin in female rats. J Toxicol Sci. 34(Suppl 1): SP73–SP81. 2009.
150. Nyska A, Pirak M, Shahar A, Scolnik M, and Waner T. Spontaneous uterine granular cell tumour in a Fischer 344 rat. Lab Anim. 25: 299–302. 1991.
151. Ohtake S, Fukui M, and Hisada S. Collaborative work on evaluation of ovarian toxicity. (1) Effects of 2- or 4-week repeated-dose administration and fertility studies with medroxyprogesterone acetate in female rats. J Toxicol Sci. 34(Suppl 1): SP23–SP29. 2009.
152. Pears AGE. Histochemistry, Theoretical and Applied, Vol Two: Analytical Technology. Churchill Livingstone, Edinburgh, London, Melbourne, New York. 1985.
153. Pedersen T, and Peters H. Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil. 17: 555–557. 1968.
154. Peluso JJ. Morphologic and physiologic features of the ovary. In: Mohr U, Dungworth DL, and Capen CC (eds). Pathobiology of the Aging Rat. ILSI Press, Washington DC. 337–349. 1992.
155. Peluso JJ, and Gordon LR. Nonneoplastic and neoplastic changes in the ovary. In: Pathobiology of the aging rat. Vol 1.Mohr U, Dungworth DL, and Capen CC (eds). ILSI Press, Washington DC. 351–364. 1992.
156. Picut CA, Aoyama H, Holder JW, Gold LS, Maronpot RR, and Dixon D. Bromoethane, chloroethane and ethylene oxide induced uterine neoplasms in B6C3F1 mice from 2-year NTP inhalation bioassays: pathology and incidence data revisited. Exp Toxicol Pathol. 55: 1–9. 2003.
157. Picut CA, Remick AK, Asakawa MG, Simons ML, and Parker GA. Histologic features of prepubertal and pubertal reproductive development in female Sprague-Dawley rats. Toxicol Pathol. 42: 403–413. 2014.
158. Picut CA, Swanson CL, Parker RF, Scully KL, and Parker GA. The metrial gland in the rat and its similarities to granular cell tumors. Toxicol Pathol. 37: 474–480. 2009.
159. Plowchalk DR, Meadows MJ, and Mattison DR. Reproductive toxicity of cyclophosphamide in the C57BL/6N mouse: 2. Effects on uterine structure and function. Reprod Toxicol. 6: 423–429. 1992.
160. Putti R, and Varano L. Histological and histochemical modifications of the uterine and vaginal mucosa of the mouse during the oestrus cycle. Basic Appl Histochem. 23: 25–37. 1979.
161. Rao GN, Hickman RL, Seilkop SK, and Boorman GA. Utero-ovarian infection in aged B6C3F1 mice. Lab Anim Sci. 37: 153–158. 1987.
162. Regan KS, Cline JM, Creasy D, Davis B, Foley GL, Lanning L, Latendresse JR, Makris S, Morton D, Rehm S, Stebbins K. STP Ovary Evaluation Working Group STP position paper: ovarian follicular counting in the assessment of rodent reproductive toxicity. Toxicol Pathol. 33: 409–412. 2005.
163. Rehm S, Dierksen D, and Deerberg F. Spontaneous ovarian tumors in Han:NMRI mice: histologic classification, incidence, and influence of food restriction. J Natl Cancer Inst. 72: 1383–1395. 1984.
164. Rehm S, Stanislaus DJ, and Wier PJ. Identification of drug-induced hyper- or hypoprolactinemia in the female rat based on general and reproductive toxicity study parameters. Birth Defects Res B Dev Reprod Toxicol. 80: 253–257. 2007.
165. Ruben Z, Arceo RJ, Bishop SP, Elwell MR, Kerns WD, Mesfin GM, Sandusky GE, and Van Vleet JF. Proliferative lesions of the heart and vasculature in rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP CV-1, Washington, DC. 1997.
166. Sakurada Y, Kudo S, Iwasaki S, Miyata Y, Nishi M, and Masumoto Y. Collaborative work on evaluation of ovarian toxicity. (5) Two- or four-week repeated-dose studies and fertility study of busulfan in female rats. J Toxicol Sci. 34(Suppl 1): SP65–SP72. 2009.
167. Sanbuissho A, Yoshida M, Hisada S, Sagami F, Kudo S, Kumazawa T, Ube M, Komatsu S, and Ohno Y. Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats. J Toxicol Sci. 34(Suppl 1): SP1–SP22. 2009.
168. Santos FC, Leite RP, Custódio AM, Carvalho KP, Monteiro-Leal LH, Santos AB, Góes RM, Carvalho HF, and Taboga SR. Testosterone stimulates growth and secretory activity of the female prostate in the adult gerbil (Meriones unguiculatus). Biol Reprod. 75: 370–379. 2006.
169. Sasahara K, Ando-Lu J, Nishiyama K, Takahashi M, Yoshida M, and Maekawa A. Granular cell foci of the uterus in Donryu rats. J Comp Pathol. 119: 195–199. 1998.
170. Sass B, and Rehm S. Tumours of the ovary. In: Pathology of tumours in laboratory animals. Vol 2. Tumours of the mouse, 2nd edition. Turusov VS, and Mohr U (eds). IARC Scientific Publications No. 111, Lyon. 493–526. 1994.
171. Sato M, Shiozawa K, Uesugi T, Hiromatsu R, Fukuda M, Kitaura K, Minami T, and Matsumoto S. Collaborative work on evaluation of ovarian toxicity. 7 Effects of 2- or 4- week repeated dose studies and fertility study of cyclophosphamide in female rats. J Toxicol Sci. 34(Suppl 1): SP83–SP89. 2009a.
172. Sato N, Uchida K, Nakajima M, Watanabe A, and Kohira T. Collaborative work on evaluation of ovarian toxicity. (13) Two- or four-week repeated dose studies and fertility study of PPAR alpha/gamma dual agonist in female rats. J Toxicol Sci. 34(Suppl 1): SP137–SP146. 2009b.
173. Seaman WJ. Postmortem change in the rat: A histologic characterization. Iowa State University Press, Ames. 1987.
174. Serov SF, Scully RE, and Sobin LH. International histological classification of tumours No 9. Histological typing of ovarian tumours. WHO, Geneva. 1–56. 1973.
175. Shibayama H, Kotera T, Shinoda Y, Hanada T, Kajihara T, Ueda M, Tamura H, Ishibashi S, Yamashita Y, and Ochi S. Collaborative work on evaluation of ovarian toxicity. (14) Two- or four-week repeated-dose studies and fertility study of atrazine in female rats. J Toxicol Sci. 34(Suppl 1): SP147–SP155. 2009.
176. Shirai M, Sakurai K, Saitoh W, Matsuyama T, Teranishi M, Furukawa T, Sanbuissho A, and Manabe S. Collaborative work on evaluation of ovarian toxicity. (8) Two- or four-week repeated-dose studies and fertility study of Anastrozole in female rats. J Toxicol Sci. 34(Suppl 1): SP91–SP99. 2009.
177. Sobis H. Yolk sac carcinoma, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 127–134. 1987.
178. Sobis H. Choriocarcinoma, uterus, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 138–140. 1987a.
179. Sobis H. Embryonal carcinoma, uterus, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 134–138. 1987b.
180. Sobis H. Teratoma, uterus, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 120–126. 1987c.
181. Squire RA, Goodman DG, Valerio MG, Fredrickson T, Strandberg JD, Levitt MH, Lingeman CH, Harshbarger JC, and Dawe CJ. Tumors. Female reproductive system. In: Pathology of laboratory animals Vol 2. Benirschke K, Garner FM, and Jones TC (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 1172–1194. 1978.
182. Steinmetz R, Mitchner NA, Grant A, Allen DL, Bigsby RM, and Ben-Jonathan N. The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract. Endocrinology. 139: 2741–2747. 1998.
183. Stewart HL, Deringer MK, Dunn TB, and Snell KC. Malignant schwannomas of nerve roots, uterus, and epididymis in mice. J Natl Cancer Inst. 53: 1749–1758. 1974.
184. Stoica G, Capen CC, and Koestner A. Sertoli’s cell tumor, ovary, rat. In: Monographs on pathology of laboratory animals. Genital system. Jones TC, Mohr U, and Hunt RD (eds). Springer, Berlin, Heidelberg, New York, Tokyo. 30–36. 1987.
185. Suckow M, Weisbroth SH, and Franklin CL. The Laboratory Rat. Elsevier Academic Press, Burlington. 2006.
186. Sundberg JP. Imperforate vagina and mucometra in mice. In: JAX NOTES Issue 441, Spring 1990. 1990.
187. Sundberg JP, and Brown KS. Imperforate vagina and mucometra in inbred laboratory mice. Lab Anim Sci. 44: 380–382. 1994.
188. Taketa Y, Yoshida M, Inoue K, Takahashi M, Sakamoto Y, Watanabe G, Taya K, Yamate J, and Nishikawa A. Differential stimulation pathways of progesterone secretion from newly formed corpora lutea in rats treated with ethylene glycol monomethyl ether, sulpiride, or atrazine. Toxicol Sci. 121: 267–278. 2011.
189. Tamura T, Yokoi R, Okuhara Y, Harada C, Terashima Y, Hayashi M, Nagasawa T, Onozato T, Kobayashi K, Kuroda J, and Kusama H. Collaborative work on evaluation of ovarian toxicity. (2) Two- or four-week repeated dose studies and fertility study of mifepristone in female rats. J Toxicol Sci. 34(Suppl 1): SP31–SP42. 2009.
190. Tan OL, Hurst PR, and Fleming JS. Location of inclusion cysts in mouse ovaries in relation to age, pregnancy, and total ovulation number: implications for ovarian cancer? J Pathol. 205: 483–490. 2005.
191. Telfer E, and Gosden RG. A quantitative cytological study of polyovular follicles in mammalian ovaries with particular reference to the domestic bitch (Canis familiaris). J Reprod Fertil. 81: 137–147. 1987.
192. Toaff ME, Abramovici A, Sporn J, and Liban E. Selective oocyte degeneration and impaired fertility in rats treated with the aliphatic monoterpene, Citral. J Reprod Fertil. 55: 347–352. 1979.
193. Tryphonas L, and Buttar HS. Genital tract toxicity of nonoxynol-9 in female rats: temporal development, reversibility and sequelae of the induced lesions. Fundam Appl Toxicol. 2: 211–219. 1982.
194. Tsubota K, Kushima K, Yamauchi K, Matsuo S, Saegusa T, Ito S, Fujiwara M, Matsumoto M, Nakatsuji S, Seki J, and Oishi Y. Collaborative work on evaluation of ovarian toxicity. (12) Effects of 2- or 4-week repeated dose studies and fertility study of indomethacin in female rats. J Toxicol Sci. 34(Suppl 1): SP129–SP136. 2009.
195. Tsujioka S, Ban Y, Wise LD, Tsuchiya T, Sato T, Matsue K, Ikeda T, Sasaki M, and Nishikibe M. Collaborative work on evaluation of ovarian toxicity. (3) Effects of 2- or 4- week repeated-dose toxicity and fertility studies with tamoxifen in female rats. J Toxicol Sci. 34(Suppl 1): SP43–SP51. 2009.
196. Tucker MJ. Diseases of the Wistar Rat. Taylor & Francis, London, Bristol. 1997.
197. Turusov MS, Munoz N, and Dunn TB. Tumours of the vagina and uterus. In: Pathology of Tumours in Laboratory Animals, Vol 2. Tumours of the Mouse. Turusov V, and Mohr U (eds). IARC Scientific Publications. 1994.
198. Usta U, Inan M, Erbas H, Aydogdu N, Oz Puyan F, and Altaner S. Tissue damage in rat ovaries subjected to torsion and detorsion: effects of L-carnitine and N-acetyl cysteine. Pediatr Surg Int. 24: 567–573. 2008.
199. van den Brink-Knol H, and van Esch E. Spontaneous malignant mixed Müllerian tumor in a Wistar rat: a case report including immunohistochemistry. Vet Pathol. 47: 1105–1110. 2010.
200. Veit AC, Painter JT, Miller RA, Hardisty JF, and Dixon D. Characterization of uterine granular cell tumors in B6C3F1 mice: a histomorphologic, immunohistochemical, and ultrastructural study. Vet Pathol. 45: 654–662. 2008.
201. Vidal JD, Mirsky ML, Colman K, Whitney KM, and Creasy DM. Reproductive System and Mammary Gland. In: Toxicologic Pathology: Nonclinical Safety Assessment. Sahota P, Popp JA, Hardisty JF, and Gopinath C (eds). CRC Press, Boca Raton. 717–830. 2013.
202. Vollmer G. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Endocr Relat Cancer. 10: 23–42. 2003.
203. Vrcić H, Horvat B, and Damjanov I. Lectin histochemistry of mouse vagina during the estrous cycle. J Histochem Cytochem. 39: 1685–1692. 1991.
204. Walker VE, Morgan KT, Zimmerman HM, and Innes JRM. Tumours of the central and peripheral nervous system. In: Pathology of tumours in laboratory animals. Vol 2. Tumours of the mouse, 2nd edition. Turusov VS, and Mohr U (eds). IARC Scientific Publications No. 111, Lyon. 731–776. 1994.
205. Wang F, Yu B, Yang W, Liu J, Lu J, and Xia X. Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res. 5: 15. 2012.
206. Ward JM, Goodman DG, Squire RA, Chu KC, and Linhart MS. Neoplastic and nonneoplastic lesions in aging (C57BL/6N x C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst. 63: 849–854. 1979.
207. Wenzel JG, and Odend’hal S. The mammalian rete ovarii: a literature review Cornell Vet. 75: 411–425. 1985.
208. Westwood FR. The female rat reproductive cycle: a practical histological guide to staging. Toxicol Pathol. 36: 375–384. 2008.
209. Yoshida M, Katsuda S, Tanimoto T, Asai S, Nakae D, Kurokawa Y, Taya K, and Maekawa A. Induction of different types of uterine adenocarcinomas in Donryu rats due to neonatal exposure to high-dose p-t-octylphenol for different periods. Carcinogenesis. 23: 1745–1750. 2002.
210. Yoshida M, Sanbuissyo A, Hisada S, Takahashi M, Ohno Y, and Nishikawa A. Morphological characterization of the ovary under normal cycling in rats and its viewpoints of ovarian toxicity detection. J Toxicol Sci. 34(Suppl 1): SP189–SP197. 2009.
211. Yoshida M, Shiraki K, Kudoh K, Ando-Lu J, Takahashi M, and Maekawa A. A uterine choriocarcinoma in a virgin Donryu rat. Toxicol Pathol. 25: 644–646. 1997.
212. Yoshida M, Watanabe G, Shirota M, Maekawa A, and Taya K. Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in donryu rats. J Reprod Dev. 51: 707–714. 2005.
213. Yuan Y. Structure, cyclic change, and function, vagina and vulva, rat. In: Monographs on Pathology of Laboratory Animals. Genital System. Springer-Verlag, Berlin, Heidelberg, New York. 161–168. 1987.
214. Yuan Y, and Foley G. Female reproductive system. In: Handbook of Toxicologic Pathology, Vol. 2. Hascheck WM, Rousseaux CG, and Wallig MA (eds). Academic Press, San Diego. 847–894. 2002.